<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">HIV- </span>
   <span class="font19">neutralizing </span>
   <span class="font17">bnAbs </span>
   <span class="font15">antibody </span>
   <span class="font15">antibodies </span>
   <span class="font15">HIV </span>
   <span class="font14">Env </span>
   <span class="font14">vaccine </span>
   <span class="font14">broadly </span>
   <span class="font14">viruses </span>
   <span class="font13">Virol../JVI.- </span>
   <span class="font13">{border-style </span>
   <span class="font13">subtype </span>
   <span class="font13">neutralization </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">Neutralizing </span>
   <span class="font12">[]. </span>
   <span class="font12">resistance </span>
   <span class="font12">[,,]. </span>
   <span class="font12">viral </span>
   <span class="font12">NAbs </span>
   <span class="font12">[,]. </span>
   <span class="font12">envelope </span>
   <span class="font12">response </span>
   <span class="font12">evolution </span>
   <span class="font12">individuals </span>
   <span class="font12">infection </span>
   <span class="font12">Antibody </span>
   <span class="font12">diversity </span>
   <span class="font12">infected </span>
   <span class="font12">protection </span>
   <span class="font11">Neutralization </span>
   <span class="font11">different </span>
   <span class="font11">vulnerability </span>
   <span class="font11">breadth </span>
   <span class="font11">human </span>
   <span class="font11">using </span>
   <span class="font11">virus </span>
   <span class="font11">Envelope </span>
   <span class="font11">T/F </span>
   <span class="font11">autologous </span>
   <span class="font11">escape </span>
   <span class="font11">increasing </span>
   <span class="font11">population </span>
   <span class="font11">sites </span>
   <span class="font11">subtypes </span>
   <span class="font11">variants </span>
   <span class="font11">bnAb </span>
   <span class="font11">effective </span>
   <span class="font11">potent </span>
   <span class="font11">px; </span>
   <span class="font11">responses </span>
   <span class="font11">sensitivity </span>
   <span class="font11">{font-family </span>
   <span class="font11">Antibodies </span>
   <span class="font11">Immunodeficiency </span>
   <span class="font11">SHIV </span>
   <span class="font11">Virus </span>
   <span class="font11">diverse </span>
   <span class="font11">font-size </span>
   <span class="font11">genetic </span>
   <span class="font11">immunodeficiency </span>
   <span class="font11">studies </span>
   <span class="font11">targeting </span>
   <span class="font11">Broadly </span>
   <span class="font11">CRF_AG </span>
   <span class="font11">Opin. </span>
   <span class="font11">Pathog.e./journal.ppat. </span>
   <span class="font11">able </span>
   <span class="font11">associated </span>
   <span class="font11">clade </span>
   <span class="font11">design </span>
   <span class="font11">development </span>
   <span class="font11">double; </span>
   <span class="font11">early </span>
   <span class="font11">epitopes </span>
   <span class="font11">highly </span>
   <span class="font11">individual </span>
   <span class="font11">infection, </span>
   <span class="font11">major </span>
   <span class="font11">prevention </span>
   <span class="font11">single </span>
   <span class="font11">specific </span>
   <span class="font11">strategies </span>
   <span class="font11">target </span>
   <span class="font11">trials </span>
   <span class="font11">type </span>
   <span class="font10">Course </span>
   <span class="font10">Figure </span>
   <span class="font10">Subtype </span>
   <span class="font10">Therefore, </span>
   <span class="font10">Type </span>
   <span class="font10">Vaccine </span>
   <span class="font10">Virol.e-./JVI.- </span>
   <span class="font10">[,,,]. </span>
   <span class="font10">bnAbs. </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">clinical </span>
   <span class="font10">consensus </span>
   <span class="font10">course </span>
   <span class="font10">immune </span>
   <span class="font10">increased </span>
   <span class="font10">leading </span>
   <span class="font10">level </span>
   <span class="font10">multiple </span>
   <span class="font10">observed </span>
   <span class="font10">patients </span>
   <span class="font10">potency </span>
   <span class="font10">pressure </span>
   <span class="font10">selection </span>
   <span class="font10">solid; </span>
   <span class="font10">time </span>
   <span class="font10">transmission </span>
   <span class="font10">vaccine. </span>
   <span class="font10">variable </span>
   <span class="font10">years </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(CDbs), </span>
   <span class="font10">AIDS./COH. </span>
   <span class="font10">Acad. </span>
   <span class="font10">AntibodiesJ. </span>
   <span class="font10">Host </span>
   <span class="font10">MPER </span>
   <span class="font10">Med../nm. </span>
   <span class="font10">Natl. </span>
   <span class="font10">Potent </span>
   <span class="font10">Resistance </span>
   <span class="font10">Sci. </span>
   <span class="font10">USA./pnas. </span>
   <span class="font10">antigenic </span>
   <span class="font10">based </span>
   <span class="font10">bold </span>
   <span class="font10">cell </span>
   <span class="font10">cells </span>
   <span class="font10">challenge </span>
   <span class="font10">circulating </span>
   <span class="font10">concentration </span>
   <span class="font10">courier; </span>
   <span class="font10">coverage </span>
   <span class="font10">data </span>
   <span class="font10">diversification </span>
   <span class="font10">elite </span>
   <span class="font10">em; </span>
   <span class="font10">epidemic </span>
   <span class="font10">epitope </span>
   <span class="font10">global </span>
   <span class="font10">greater </span>
   <span class="font10">immunogens </span>
   <span class="font10">important </span>
   <span class="font10">infecting </span>
   <span class="font10">isolated </span>
   <span class="font10">molecular </span>
   <span class="font10">monoclonal </span>
   <span class="font10">neutralize </span>
   <span class="font10">overcome </span>
   <span class="font10">patterns </span>
   <span class="font10">potential </span>
   <span class="font10">pt;} </span>
   <span class="font10">recent </span>
   <span class="font10">region </span>
   <span class="font10">resistant </span>
   <span class="font10">specificities </span>
   <span class="font10">strains </span>
   <span class="font10">vitro </span>
  </p>
 </body>
</html>
